| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.86B | 7.18B | 6.43B | 5.96B | 6.29B | 5.93B |
| Gross Profit | 3.26B | 2.89B | 2.46B | 1.88B | 1.63B | 1.85B |
| EBITDA | 7.98B | 13.34B | 7.78B | 10.47B | 19.15B | 7.75B |
| Net Income | 5.71B | 5.24B | 2.85B | 4.33B | 12.22B | 5.30B |
Balance Sheet | ||||||
| Total Assets | 80.21B | 73.27B | 62.27B | 65.50B | 71.32B | 53.82B |
| Cash, Cash Equivalents and Short-Term Investments | 22.34B | 18.33B | 19.26B | 21.28B | 13.65B | 6.45B |
| Total Debt | 18.17B | 16.82B | 16.50B | 16.45B | 16.15B | 8.27B |
| Total Liabilities | 24.55B | 22.06B | 20.99B | 20.89B | 21.19B | 12.96B |
| Stockholders Equity | 24.28B | 22.18B | 17.87B | 18.96B | 20.58B | 29.19B |
Cash Flow | ||||||
| Free Cash Flow | 1.85B | 1.77B | 936.00M | -479.00M | -981.00M | -62.00M |
| Operating Cash Flow | 1.96B | 1.91B | 1.03B | -177.00M | -702.00M | 73.00M |
| Investing Cash Flow | 16.04B | 11.78B | 142.00M | 12.55B | 5.91B | -731.00M |
| Financing Cash Flow | -9.43B | -8.51B | -8.24B | -12.10B | 894.00M | 53.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $17.50B | 8.98 | 51.49% | ― | 16.79% | 819.94% | |
75 Outperform | $43.78B | 127.24 | 15.22% | ― | 69.71% | ― | |
71 Outperform | $23.23B | 16.98 | 14.47% | 1.02% | 13.86% | 80.97% | |
69 Neutral | $52.11B | 9.39 | 25.30% | 0.27% | 13.95% | 249.74% | |
68 Neutral | $51.35B | 47.76 | 3.31% | ― | -2.70% | -56.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | $12.95B | -25.54 | -22.38% | ― | 11.75% | 49.19% |